NASDAQ:FNYFirst Trust Mid Cap Growth AlphaDEX Fund Stock Price, Forecast & News

First Trust Mid Cap Growth AlphaDEX Fund's stock was trading at $39.37 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, FNY stock has increased by 30.1% and is now trading at $51.21.
View which stocks have been most impacted by Coronavirus.

First Trust Mid Cap Growth AlphaDEX Fund declared a quarterly dividend on Wednesday, March 25th. Shareholders of record on Friday, March 27th will be given a dividend of $0.004 per share on Tuesday, March 31st. This represents a $0.02 dividend on an annualized basis and a yield of 0.03%. The ex-dividend date of this dividend is Thursday, March 26th.
View First Trust Mid Cap Growth AlphaDEX Fund's dividend history.

Media stories about FNY stock have been trending negative this week, InfoTrie reports. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. First Trust Mid Cap Growth AlphaDEX Fund earned a media sentiment score of -2.2 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future.
View the latest news about First Trust Mid Cap Growth AlphaDEX Fund.

Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust Mid Cap Growth AlphaDEX Fund investors own include Adobe (ADBE), Erie Indemnity (ERIE), EXACT Sciences (EXAS), First Trust Dow Jones Internet Index Fund (FDN), IDEXX Laboratories (IDXX), Kinsale Capital Group (KNSL), Mastercard (MA), Veracyte (VCYT), AMN Healthcare Services (AMN) and Advanced Micro Devices (AMD).

First Trust Mid Cap Growth AlphaDEX Fund trades on the NASDAQ under the ticker symbol "FNY."

First Trust Mid Cap Growth AlphaDEX Fund's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include UBS Group AG (4.78%), Savior LLC (2.86%), First Heartland Consultants Inc. (1.75%), Envestnet Asset Management Inc. (1.66%), Raymond James Financial Services Advisors Inc. (0.99%) and Sigma Planning Corp (0.71%).

FNY stock was sold by a variety of institutional investors in the last quarter, including Raymond James & Associates, First Trust Advisors LP, NEXT Financial Group Inc, Envestnet Asset Management Inc., UBS Group AG, Cambridge Investment Research Advisors Inc., CWM LLC, and Stonebridge Financial Planning Group LLC.

FNY stock was bought by a variety of institutional investors in the last quarter, including Savior LLC, First Heartland Consultants Inc., Raymond James Financial Services Advisors Inc., HNP Capital LLC, Sigma Planning Corp, Great Valley Advisor Group Inc., Cypress Wealth Services LLC, and Stratos Wealth Partners LTD..

Shares of FNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of FNY stock can currently be purchased for approximately $51.21.

First Trust Mid Cap Growth AlphaDEX Fund has a market capitalization of $337.99 million.